8-K/ALeadership Changes

IDEXX LABORATORIES INC /DE 8-K/A Report, Executive Changes (Feb 16, 2017)

Filed February 16, 2017For Securities:IDXX

Summary

This filing is an amendment (8-K/A) to a previous Current Report on Form 8-K, specifically addressing the election of Lawrence D. Kingsley to the IDEXX Laboratories, Inc. Board of Directors. The amendment clarifies that there are no related-party transactions involving Mr. Kingsley that need to be disclosed under SEC regulations. The core information remains the appointment of Mr. Kingsley as an independent director, effective October 19, 2016, and his subsequent committee assignments, alongside an adjustment to the board size to accommodate this change.

Key Highlights

  • 1IDEXX Laboratories appointed Lawrence D. Kingsley as an independent Class II Director to its Board of Directors on October 19, 2016.
  • 2Mr. Kingsley has been appointed to serve on the Board's Compensation and Finance Committees.
  • 3The total number of directors on the Board was increased from nine to ten to facilitate Mr. Kingsley's appointment.
  • 4Mr. Kingsley's term as a Class II Director is expected to align with the 2017 annual meeting of stockholders, with a three-year term expiring in 2020.
  • 5This amendment clarifies the absence of any reportable related-person transactions involving Mr. Kingsley.
  • 6Mr. Kingsley will receive compensation consistent with other non-employee directors, with prorated fees for the fourth quarter of 2016 and prorated stock grants for his partial service year.
  • 7The original report included a press release announcing Mr. Kingsley's election.

Frequently Asked Questions

The primary purpose of this amendment (8-K/A) is to clarify that there are no related-person transactions to be disclosed concerning the newly elected director, Lawrence D. Kingsley, as required by SEC regulations. It amends a previous Form 8-K filing that reported his election.

Lawrence D. Kingsley was elected as an independent Class II Director to the Board of Directors of IDEXX Laboratories, Inc. on October 19, 2016. He also serves on the Board's Compensation and Finance Committees.

Mr. Kingsley will receive the standard compensation provided to IDEXX's other non-employee directors. This includes prorated cash fees for his service in the fourth quarter of 2016 and prorated stock unit and option grants, reflecting his partial service from his election date until the 2017 annual meeting.

Yes, the size of the Board of Directors was increased from nine to ten members to accommodate the election of Mr. Kingsley as a Class II Director.